Vanguard Group Inc Amneal Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 14,623,944 shares of AMRX stock, worth $123 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,623,944
Previous 13,994,178
4.5%
Holding current value
$123 Million
Previous $88.9 Million
36.92%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AMRX
# of Institutions
185Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$183 Million0.04% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$104 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$94.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$90.2 Million2.48% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.89MShares$74.8 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.27B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...